Pharmiva AB (PHARM)

Currency in SEK
0.77
0.00(0.00%)
Real-time Data·
Showing Pharmiva AB historical data. For real-time data please try another search
Day's Range
0.650.82
52 wk Range
0.560.82
Key Statistics
Prev. Close
0.67
Open
0.67
Day's Range
0.65-0.82
52 wk Range
0.56-0.82
Volume
-
Average Volume (3m)
20.69K
1-Year Change
37.5%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Pharmiva AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Pharmiva AB Company Profile

As of November 21, 2023, Pharmiva AB (publ) was acquired by PEPTONIC medical AB (publ). Pharmiva AB (publ) engages in the research and development of medical products in Sweden. The company offers Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company was incorporated in 2015 and is headquartered in Lund, Sweden.

Employees
5
Market
Sweden

Pharmiva AB Earnings Call Summary for Q4/2024

  • Q4 2024 revenues up 141.4% YoY; full-year 2024 revenues rose 21% to $297 million
  • 2025 revenue guidance: $315-335 million, projecting 6-13% growth
  • Ruconest revenue up 11% to $252 million; Joenja revenue surged 147% to $45 million
  • Focus on rare diseases; expanding indications for key products
  • Stock potentially undervalued; analysts set price targets between $1.52 and $2.34
Last Updated: 13/03/2025, 15:30
Read Full Transcript

Earnings

Latest Release
Nov 22, 2023
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PHARM Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.